Home » Blogs » The Carlat Psychiatry Blog

The Carlat Psychiatry Blog
RSS

BOOK REVIEWS FOR PSYCHIATRISTS

A Review of Sexual Citizens

Stories that color-in the stark lines of evidence-based medicine.

March 14, 2023

Emily E. Whisler, DO and Edmund S. Higgins, MD.

College today is not your grandfather’s alma mater.

BOOK REVIEWS FOR PSYCHIATRISTS

Using Stories to Color the Stark Lines of Evidence-Based Medicine: Elyn R. Saks

February 9, 2023

Emily E. Whisler, DO and Edmund S. Higgins, MD.

The first in a series of interesting reading for psychiatrists

The Top 10 Episodes of the Carlat Psychiatry Podcast in 2022

December 29, 2022

The Carlat Reports present updates on clinical psychiatry on a weekly basis. What were the most listened to episodes of 2022? We'll start the countdown at #10.

Q&A

Overview of Psychological Assessment Before Bariatric Surgery

December 5, 2022

Stephanie Sogg, PhD

A constellation of factors contributes to successful outcomes in weight loss surgery and one of them is a thorough assessment.

CARLAT IN THE NEWS

Dr. Carlat Appears on NPR/WBUR's On Point

November 14, 2022

A guest on NPR's On Point about a systematic review on the "chemical imbalance" theory, Dr. Carlat relays his experience as a practicing psychiatrist.

Gold Star Program Reduces Prior-Auth Burdens

April 13, 2022

Tony Thrasher, DO, DFAPA

Texas state legislators recently passed a bill that will greatly reduce the prior authorization workload. Will this open the door to the rest of the country?

Pros and Cons of Using Oxcarbazepine Over Carbamazepine

August 28, 2020

Does the limited research support that oxcarbazepine is a safer and more effective treatment for bipolar disorder than its FDA-approved cousin, carbamazepine? Here is an overview of the pros and cons from a previous article in The Carlat Psychiatry Report.Pros:Similar effectiveness as other mood stabilizers. In mania and mixed states,...

Tips on Choosing an Antipsychotic for Schizophrenia

August 26, 2020

Which antipsychotics should we consider selecting as the first-line and second-line treatments, and what should we base this decision on? Dr. Aziz addresses this in a past article from The Carlat Psychiatry Report. Here’s some of his advice:Process: Tolerability instead of efficacy should be considered when selecting a first-line treatment.

Tips on the Doubts about Ketamine/Esketamine

August 19, 2020

Ketamine and esketamine have been shown to provide rapid relief of suicidality, however, many lingering doubts have been raised about these medicines. In a previous article from The Carlat Psychiatry Report, Nolan Williams, M.D., discusses the potential negative consequences of ketamine/esketamine treatment. Here are some of Dr. Williams’s tips:It might...

Navigating the World of Mental Health Apps

August 18, 2020

Many mental health apps can be problematic because "most of the apps that are available are poorly designed and lack research support.” Dr. Torous discusses these apps in an article from The Carlat Psychiatry Report. Here is some of his advice.